undamentalytics Newsletter
Sign in

Quanterix Corp revenue

Quanterix Corp's revenue was $139m in fiscal 2025, up 1.1% on the year before. Since fiscal 2016 ($17.6m) it has grown at a compound 25.8% a year. Over the last twelve months it was $153m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1823385786111106122137139153
Growth on the year before—+30.1%+64.5%+50.8%+52.2%+28.0%−4.6%+16.0%+12.3%+1.1%—
Gross profit810182748654574836565

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Products $92.9M ▲ 16.6%
Consumable and Other Products $75.1M ▲ 8.4%
Simoa Product Revenue $71M ▼ 10.9%
Service and Other Revenue $44.2M ▼ 13.7%
Simoa Service and Other Revenue $32.4M ▼ 36.8%
Research Services $26M ▼ 31.6%
Spatial Product Revenue $21.9M —
Instrument Products $17.9M ▲ 70.4%
Spatial Service and Other Revenue $11.8M —
Service Type Warranties $11.1M ▲ 5.0%
Other Services $7.1M ▲ 168.6%
Licenses and services $1.5M ▼ 66.3%
Grant $243,000 ▼ 87.8%

These categories overlap or exclude eliminations, so shares aren't shown.

From Quanterix Corp's 10-K filed March 2, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Quanterix Corp $153m 22.0% 11.1%
Pacific Biosciences Of California, Inc. $159m 2.0% 2.9%
Grail, Inc. $165m 23.1% —
Cryoport, Inc. $186m 12.1% -8.2%
Cytek Biosciences, Inc. $207m 5.4% 5.6%
Maravai Lifesciences Holdings, Inc. $209m -5.0% -27.3%

Compare with peers

Head to head: PACB vs QTRXGRAL vs QTRXCYRX vs QTRX

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Quanterix Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quanterix Corp.